Gilles DivitaCEO at Divincell SAS
Dr. Gilles Divita is founder and CEO of DIVINCELL, a BioPharmaceutical NanoMedicine Start-up pioneering a novel drug delivery technology for the treatment of cancer and genetic diseases. Dr Divita has over 25 years of experience in drug delivery systems, peptide-drugs and oligonucleotide therapeutics. He is one of the pioneers of the “non covalent cell penetrating peptide-based strategy” for therapeutic delivery.
Dr. Divita holds a Ph.D. in Biochemistry/Biophysic from the University in Lyon, France. He worked as Post Doc at the Max Planck Institute in Heidelberg-Germany and as Associate Professor at the SCRIPPS Research Institute, La jolla, USA. In 1996, Dr. Divita joined the French National Center for Scientific Research (CNRS) and was Research Director, head of Chemical Biology and Nanotechnology for Therapeutics Team at the CNRS in Montpellier-France up to 2016.